ASTRAZENECA PLC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge
SEC filing record 1 source field available
Fiscal year end
31 December
ASTRAZENECA PLC has filed 2,049 SEC EDGAR filings since 13 Mar 1995

SEC filing history

Showing 126-150 of 1,000 matching filings.

Per page
25
Current page
6
6-K File 001-11960

ASTRAZENECA MANUFACTURING INVESTMENT IN MARYLAND

Filing date
24 Nov 2025
Reporting date
24 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

KOSELUGO (SELUMETINIB) APPROVED IN THE US

Filing date
20 Nov 2025
Reporting date
20 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

HOLDING(S) IN COMPANY

Filing date
17 Nov 2025
Reporting date
17 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-11960

25-NSE filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
14 Nov 2025
Reporting date
14 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-11960

144 filing

Filing date
12 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
10 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

9M AND Q3 2025 RESULTS

Filing date
06 Nov 2025
Reporting date
06 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

RESULT OF GENERAL MEETING

Filing date
03 Nov 2025
Reporting date
03 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
03 Nov 2025
Reporting date
03 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FORM 6-K

Filing date
03 Nov 2025
Reporting date
03 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR DECLARATION

Filing date
28 Oct 2025
Reporting date
28 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

KOSELUGO (SELUMETINIB) APPROVED IN THE EU

Filing date
28 Oct 2025
Reporting date
28 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TEZSPIRE APPROVED IN EU FOR CRSWNP

Filing date
22 Oct 2025
Reporting date
22 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

US FDA APPROVES TEZSPIRE IN CRSWNP

Filing date
20 Oct 2025
Reporting date
20 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

POSITIVE CHMP OPINION FOR SUBCUTANEOUS SAPHNELO

Filing date
20 Oct 2025
Reporting date
20 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

AGREEMENT WITH US GOVT TO LOWER MEDICINE PRICES

Filing date
14 Oct 2025
Reporting date
14 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

BAXDROSTAT MET PRIMARY ENDPOINT IN BAX24 PH3 TRIAL

Filing date
07 Oct 2025
Reporting date
07 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DATROWAY IMPROVED OS AND PFS IN TROPION-BREAST02

Filing date
06 Oct 2025
Reporting date
06 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
01 Oct 2025
Reporting date
01 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ENHERTU IMPROVED IDFS IN EARLY BC IN DB-05

Filing date
29 Sep 2025
Reporting date
29 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

AZN HARMONISES LISTING STRUCTURE

Filing date
29 Sep 2025
Reporting date
29 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

6-K

Filing date
29 Sep 2025
Reporting date
29 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
25 Sep 2025
Reporting date
25 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

KOSELUGO RECOMMENDED FOR EU APPROVAL

Filing date
22 Sep 2025
Reporting date
22 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .